Is a Change of Factor VIII Product a Risk Factor for the Development of a Factor VIII Inhibitor?

Thynn Thynn Yee; C. A. Lee

doi:10.1055/s-0037-1614585

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1999; 81(05): 852
DOI: 10.1055/s-0037-1614585

Letters to the Editor

Schattauer GmbH

Is a Change of Factor VIII Product a Risk Factor for the Development of a Factor VIII Inhibitor?

Thynn Thynn Yee

¹From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.

,

C. A. Lee

¹From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.

› Author Affiliations

Abstract

Full Text

References

References
1 Baglin T, Beacham E.. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? Thromb Haemost. 1998; 80:: 1036-7.
2 Yee TT, Lee CA, Riddel A, Pasi KJ. From Tolerance to Intolerance of factor VIII: A Clinical Case Presentation. C.M.E.. Bulletin 1997; 1: 16-7.
3 Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, de Moerloose P, Morris MA. Molecular etiology of factor VIII deficiency in haemophilia A. Advances in experimental medicine and biology.. Ed by Aledort L. M., Hoyer L. W., Lusher J. M., Reisner H. M., and C. G.. White II. 1996; 386: 19-34.
4 Lee CA. Investigation of chronic hepatitis C infection in individuals with haemophilia.. Br J Haematol 1997; 96: 425